On The Dark Side Of Pharma -- A Worthy Read, In The Nation, This Morning...

In the distant past, I used to offer much more fare like this -- and less so, more recently. It may be time to return to it.

I'll just link to it, and quote a tiny bit:

. . . .[These] price spikes have received surprisingly little media scrutiny given the widespread coverage of the opioid crisis and the viral outrage over drug company greed, from pharma bro Martin Shkreli to Mylan’s profiteering from EpiPens (as mentioned above, Mylan also produces naloxone). . . .

That’s likely because naloxone patients aren’t as sympathetic as the children and parents buying EpiPens. They are opioid users. And despite the fact that the white face of the opioid crisis tends to elicit the sort of public and political empathy that was never offered to black crack users in the 1980s, drug use remains heavily stigmatized. . . .

Do go read it all. That's all I've got, this Friday morning.

नमस्ते